29/2021・Trifork completes strategic review of Dawn Health A/S. Upgrades 2021 EBIT guidance to EURm 34-36.5 (previously EURm 13-15.5) November 30, 2021 GlobeNewswire Source: Software Share on Facebook Share Share on TwitterTweet Share on Google Plus Share Share on Pinterest Share Share on LinkedIn Share Share on Digg Share